Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2908-2913
Published online before print November 20, 2003, doi: 10.1161/01.STR.0000100158.51986.EB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/12/2908    most recent
01.STR.0000100158.51986.EBv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosche, B.
Right arrow Articles by Heiss, W.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosche, B.
Right arrow Articles by Heiss, W.-D.
Related Collections
Right arrow Acute Cerebral Infarction

(Stroke. 2003;34:2908.)
© 2003 American Heart Association, Inc.


Original Contributions

Extracellular Concentrations of Non–Transmitter Amino Acids in Peri-Infarct Tissue of Patients Predict Malignant Middle Cerebral Artery Infarction

Bert Bosche, MD; Christian Dohmen, MD; Rudolf Graf, PhD; Michael Neveling, MD; Frank Staub, MD; Lutz Kracht, MD; Jan Sobesky, MD; Fritz-Georg Lehnhardt, MD Wolf-Dieter Heiss, MD

From the Max Planck Institute for Neurological Research (B.B., C.D., R.G., L.K., J.S., W-D.H.), Cologne, Germany; and Departments of Neurology (B.B., C.D., M.N., J.S., F-G.L., W-D.H.) and Neurosurgery (F.S.), University of Cologne, Cologne, Germany.

Correspondence to Bert Bosche, MD, Max Planck Institut fuer neurologische Forschung, Gleulerstrasse 50, D-50931 Koeln, Germany. E-mail bbosche{at}pet.mpin-koeln.mpg.de

Background and Purpose— Space-occupying brain edema is a life-threatening complication in patients with large middle cerebral artery (MCA) infarction. To determine predictors of this detrimental process, we investigated alterations of extracellular non–transmitter amino acid concentrations in peri-infarct tissue.

Methods— Thirty-one patients with infarctions covering >50% of the MCA territory in early cranial CT scans were included in the study. Probes for microdialysis, intracranial pressure, and tissue oxygen pressure were placed into the noninfarcted ipsilateral frontal lobe. Positron emission tomography imaging was performed in 16 of these patients to measure cerebral blood flow in the tissue around the neuromonitoring probes.

Results— Fourteen of the 31 patients developed a malignant MCA infarction, and 17 did not. The patients in the malignant group had significantly lower extracellular concentrations of non–transmitter amino acids than those in the benign group in the first 12 hours of neuromonitoring. At this time, CBF values determined in regions of interest around the probes by positron emission tomography and tissue oxygen pressure showed that the monitored tissues were not yet infarcted, and no differences in transmitter amino acids concentrations were found between the 2 groups. Furthermore, extracellular concentrations of non–transmitter amino acids were negatively correlated with size of infarction.

Conclusions— We assume that reduction of non–transmitter amino acid concentrations reflects an expansion of the extracellular space by vasogenic edema formation in peri-infarct tissue of patients with malignant MCA infarction. Our findings facilitate early prediction of malignant edema formation and may help to increase knowledge of the pathophysiology of the peri-infarct zone of large MCA infarction.


Key Words: amino acids • brain edema • cerebral infarction • middle cerebral artery




This article has been cited by other articles:


Home page
StrokeHome page
C. Dohmen, B. Bosche, R. Graf, T. Reithmeier, R.-I. Ernestus, G. Brinker, J. Sobesky, and W.-D. Heiss
Identification and Clinical Impact of Impaired Cerebrovascular Autoregulation in Patients With Malignant Middle Cerebral Artery Infarction
Stroke, January 1, 2007; 38(1): 56 - 61.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Bosche, G. F. Hamann, C. Dohmen, R. Graf, J. Serena, M. Castellanos, J. Castillo, M. Blanco, and A. Davalos
There Is More to it Than: the Greater the Infarction Volume, the More Probable Is a Malignant MCA Infarction
Stroke, March 1, 2006; 37(3): 762 - 764.
[Full Text] [PDF]


Home page
StrokeHome page
A. Bhardwaj, B. Bosche, C. Dohmen, and R. Graf
In Vivo Regional Neurochemistry in Stroke: Clinical Applications, Limitations, and Future Directions * Cerebral Microdialysis in Stroke Patients: Potentials and Limitations of a Method with Longitudinal Information: Response
Stroke, April 1, 2004; 35(4): e74 - e76.
[Full Text] [PDF]


Home page
StrokeHome page
C. Berger and S. Schwab
Editorial Comment--"Malignant" or Not: Is There a Role for In Vivo Neurochemistry?
Stroke, December 1, 2003; 34(12): 2914 - 2915.
[Full Text] [PDF]